Unichem Laboratories Ltd share price logo

Unichem Laboratories Share Price

NSE: UNICHEMLAB

BSE: 506690

Small Cap

Healthcare Sector

₹367.05

+1.45

(+0.40%)

as on

bell
The current prices are delayed by 15 mins, login to check live prices.

Tech Chart

Unichem Laboratories Stock Performance

as on February 20, 2026 at 9:31 pm IST

  • Day's Low

    Day's High

    ₹362.25
    ₹369.90
    downward going graph

    1.31%

    Downside

    0.78%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    ₹361.05
    ₹722.35
    downward going graph

    1.63%

    Downside

    96.80%

    Upside

    downward going graph

Unichem Laboratories share price movements today

Previous Close
₹365.60
Open
₹369.90
Volume
13.10K
Upper Circuit
₹438.70
Lower Circuit
₹292.50
Day's Low - High
₹362.25 - ₹369.90
52 Week Low - High
₹361.05 - ₹722.35

Unichem Laboratories Historical Returns

1 Month Return
-2.88 %
3 Month Return
-21.3 %
1 Year Return
-46.66 %
3 Year Return
+ 13.04 %
5 Year Return
+ 16.95 %

Unichem Laboratories Fundamentals

as on February 20, 2026 at 4:01 pm IST

Market Cap

₹2,584.24 Cr

Return on Equity (ROE)

6.86

PE Ratio (TTM)

8.76

Return on capital employed (ROCE)

7.58

Industry PE ratio

41.35

Beta (LTM)

1.18

P/B Ratio

1.98

Dividend Yield

0

PEG Ratio

0.18

Quarterly Earnings Growth YOY

356.85

EPS (TTM)

19.53

Sector

Pharmaceuticals

Book Value

348.1

Unichem Laboratories Stock Valuation

as on February 20, 2026 at 4:01 pm IST

Unichem Laboratories in the last 5 years

  • Overview

  • Trends

Lowest (-1720.62x)

October 1, 2021

Today (8.76x)

February 20, 2026

Industry (41.35x)

February 20, 2026

Highest (1039.54x)

February 5, 2024

LowHigh

Today’s Price to Earnings Ratio: 8.76x

Unichem Laboratories Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Unichem Laboratories with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
Unichem Laboratories Ltd image
Unichem Laboratories Ltd
NA2,584.243.39%0.581372,110
Shukra Pharmaceuticals Ltd image
Shukra Pharmaceuticals Ltd
NA1,639.423100%0.00932
Strides Pharma Science Ltd image
Strides Pharma Science Ltd
BUY8,015.80-0.1%0.723,5974,565
Kilitch Drugs (India) Ltd image
Kilitch Drugs (India) Ltd
BUY548.6351.78%0.6024198
FDC Ltd image
FDC Ltd
NA6,006.065.71%0.512662,108
See all

Unichem Laboratories Stock’s Investor Sentiment and Interest

Search interest for Unichem Laboratories Ltd Stock has increased by 278% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:278% versus previous 30 day period

Unichem Laboratories Ltd Quarterly Profit & Loss

Figures in Rupees Crores

Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Sales
402.1
423.19
415.63
465.72
431.7
483.34
507.36
533.09
587.18
526.6
578.96
521.17
Other Income
5.11
8.63
5.54
79.28
6.15
3.76
8.69
13.62
9.25
6.82
20.97
287.32
Total Income
407.21
431.82
421.16
545
437.85
487.1
516.05
546.71
596.43
533.42
599.93
808.49
Expenses
419.16
395.17
406.87
434.6
531.97
443.19
451.87
447.57
503.48
504.11
571.04
476.39
Operating Profit
-17.06
28.02
8.76
31.12
-100.27
40.15
55.49
85.52
83.7
22.49
7.92
44.78
Operating Profit Margin %
-4.24%
6.62%
2.11%
6.68%
-23.23%
8.31%
10.94%
16.04%
14.25%
4.27%
1.37%
8.59%
Profit Before Interest, Tax and Depreciation
-11.95
36.65
14.3
110.4
-94.12
43.91
64.18
99.14
92.95
29.31
28.89
332.1
Interest
5.52
5.76
6.73
5.58
4.59
4.03
4.79
6.75
5.46
6.54
8.24
7.42
Depreciation
29.68
28.77
29.45
31.62
27.16
32.07
32.26
30.54
29.69
31.79
31.47
31.25
Profit Before Tax
-47.15
2.12
-21.88
73.2
-125.87
7.81
27.13
61.85
57.8
-9.02
-10.82
293.43
Tax Paid
-2.89
2.79
2.6
-0.02
3.44
5.74
2.5
4
4.83
1.45
1.07
29.14
Profit After Tax
-44.27
-0.67
-24.49
73.22
-129.31
2.07
24.63
57.85
52.97
-10.47
-11.89
264.29
Total Net profit including share of profit / Loss from associate company
-44.27
-0.67
-24.49
73.22
-129.31
2.07
24.63
57.85
52.97
-10.47
-11.89
264.29
EPS
-6.28
-0.09
-3.48
10.39
-18.37
0.29
3.5
8.22
7.52
-1.49
-1.69
37.54
Actual EPS
-6.28
-0.09
-3.48
10.39
-18.37
0.29
3.5
8.22
7.52
-1.49
-1.69
37.54
Adjusted EPS
-6.28
-0.09
-3.48
10.39
-18.37
0.29
3.5
8.22
7.52
-1.49
-1.69
37.54
Diluted EPS
-6.28
-0.09
-3.48
10.39
-18.36
0.29
3.49
8.19
7.5
-1.49
-1.69
37.47

Unichem Laboratories Ltd Annual Profit & Loss

Figures in Rupees Crores

Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Sales
697.71
814.59
1,180.05
1,103.71
1,235.14
1,269.83
1,343.02
1,785.11
2,110.97
Other Income
185.09
2,738.88
100.24
92.13
50.19
47.51
38.52
31.59
35.32
Total Income
882.8
3,553.47
1,280.28
1,195.84
1,285.32
1,317.34
1,381.54
1,816.7
2,146.29
Expenses
739.11
946.71
1,263.54
1,154.53
1,144.37
1,198.1
1,427.14
1,755.84
1,846.11
Operating Profit
-41.4
-132.12
-83.49
-50.82
90.77
71.73
-84.12
29.27
264.86
Operating Profit Margin %
-5.93%
-16.22%
-7.08%
-4.6%
7.35%
5.65%
-6.26%
1.64%
12.55%
Profit Before Interest, Tax and Depreciation
143.7
2,606.77
16.74
41.31
140.95
119.24
-45.61
60.86
300.18
Interest
3.36
8.01
7.52
7.85
5.12
6.11
17.31
22.66
21.03
Depreciation
43.52
50.51
67.37
81.67
84.36
91.17
113.44
123.16
124.56
Profit Before Tax
96.82
2,548.25
-58.15
-48.21
51.47
21.96
-176.36
-84.96
154.59
Tax Paid
-11.85
3.34
-34.35
11.97
17.15
-11.09
25.86
8.8
17.07
Profit After Tax
108.68
2,544.91
-23.8
-60.18
34.32
33.06
-202.23
-93.76
137.52
Total Net profit including share of profit / Loss from associate company
108.68
2,544.91
-23.8
-60.18
34.32
33.06
-202.23
-93.76
137.52
EPS
11.96
280.6
-3.63
-8.55
4.88
4.7
-28.72
-13.32
19.53
Actual EPS
11.96
280.6
-3.63
-8.55
4.88
4.7
-28.72
-13.32
19.53
Adjusted EPS
11.96
280.6
-3.63
-8.55
4.88
4.7
-28.72
-13.32
19.53
Diluted EPS
11.94
280.41
-3.63
-8.55
4.88
4.68
-28.72
-13.32
19.47

Unichem Laboratories Ltd Cash Flow

Figures in Rupees Crores

Mar 2016
Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Net Cash from Operating Activities
111.72
68.19
-112.34
-327.77
19.82
32.98
-259.61
-85.09
14
-7.02
Cash Flow from Investing Activities
-85.12
-127.87
1,648.34
-286.01
-35.91
-65.97
100.11
240.94
63.31
-241.91
Cash Flow from Financing Activities
-33.43
59.23
-881.14
-2.42
-62.3
-121.08
191.23
-81.3
-106.31
183.76
Net Cash Flow
-6.84
-0.46
654.86
-616.19
-78.4
-154.06
31.74
74.56
-29
-65.17

Unichem Laboratories Stock Shareholding Pattern

Numbers in percentages

Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Promoters
50.93%
50.93%
70.21%
70.22%
70.22%
70.22%
70.22%
70.22%
70.22%
70.22%
70.22%
70.22%
DII
8.16%
7.39%
10.32%
9.29%
11.27%
11.58%
11.67%
11.63%
11.32%
10.92%
10.75%
10.74%
FII
0%
0%
0.83%
0%
0.9%
0.89%
0.94%
1.06%
0.98%
0.98%
1%
0.99%
Public
39.21%
37.72%
18.64%
18.18%
17.61%
17.3%
17.18%
17.09%
17.48%
17.88%
18.03%
18.05%
Total Outstanding Shares
7,04,05,750
7,04,05,750
7,04,05,750
7,04,05,750
7,04,05,750
7,04,05,750
7,04,05,750
7,04,05,750
7,04,05,750
7,04,05,750
7,04,05,750
7,04,05,750
Total Shareholders
29,418
26,642
21,584
20,877
21,171
20,621
20,374
21,472
21,621
23,010
23,577
23,267

Mutual Funds that own Unichem Laboratories Stock

Check out the Mutual Funds with significant holdings in Unichem Laboratories.

Unichem Laboratories Corporate Actions

View detailed summary of the earnings and dividend history of Unichem Laboratories.

  • Unichem Laboratories Ltd Earnings Results

    Unichem Laboratories Ltd’s net profit jumped 356.85% since last year same period to ₹264.29Cr in the Q3 2025-2026. On a quarterly growth basis, Unichem Laboratories Ltd has generated 2322.79% jump in its net profits since last 3-months.

    Read More about Earnings Results

  • Unichem Laboratories Ltd Dividends May,2022

    In the quarter ending March 2022, Unichem Laboratories Ltd has declared dividend of ₹4.00 per share on 27 May 2022 - translating a dividend yield of 2.18%.

    Read More about Dividends

Indices Featuring Unichem Laboratories Stock

Check stock indices that include Unichem Laboratories.

BSE Healthcare

₹43,085.48

0.11 (▲45.21%)

Insights on Unichem Laboratories Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 3 quarters, 533.42 Cr → 808.49 Cr (in ₹), with an average increase of 18.4% per quarter

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, -11.89 Cr → 264.29 Cr (in ₹), with an average increase of 104.5% per quarter

  • imgPOSITIVE IMPACT

    Retail Holding Up

    img

    Retail Investor have increased holdings from 18.03% to 18.05% in Dec 2025 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Torrent Pharmaceuticals Ltd has given 185.7% return, outperforming this stock by 172.6%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Torrent Pharmaceuticals Ltd has given 39.6% return, outperforming this stock by 86.2%

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 70.22% of holdings in Dec 2025 quarter

  • imgNEGATIVE IMPACT

    FII Holding Down

    img

    Foreign Institutions have decreased holdings from 1.00% to 0.99% in Dec 2025 quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 1 year, UNICHEMLAB stock has moved down by -46.7%

About Unichem Laboratories Ltd

Unichem Laboratories Ltd is an India based pharmaceutical company, headquartered in Mumbai, specialising in the manufacture of active pharmaceutical ingredients (API). Founded in 1962, the company has five manufacturing facilities in Roha, Maharashtra; Goa; Ghaziabad, Uttar Pradesh; Pithampur, Madhya Pradesh; and Baddi, Himachal Pradesh, all of which have been certified ISO 9001:2000 and ISO 14001:2004. Over the years, Unichem Laboratories Ltd has formed collaborations and acquired subsidiaries such as Uni Sankyo Co.Marketing Formulations, Medical Corporation South Africa, Unisearch Ltd., Niche Generics Ltd., and Unichem Pharmaceuticals USA Inc. In 2019, they set up their first subsidiary in China, Younikaimo Pharmaceutical Shanghai Private Limited. The company recently sold their domestic formulations business, and manufacturing facility at Sikkim, on a going concern basis, to Torrent Pharmaceuticals Limited. They remain at the forefront of the pharmaceutical industry with their commitment to innovation and quality.

Revenue: ₹521.17Cr as on December 2025 (Q3 FY26)
Net Profit: ₹264.29Cr as on December 2025 (Q3 FY26)
Listing date: 10 Jan, 1995
Chairperson Name: Prakash A Mody
OrganisationUnichem Laboratories Ltd
HeadquartersMumbai
IndustryPharmaceuticals
CEOPrakash A Mody
E-voting on sharesClick here to vote

FAQs

What is Unichem Laboratories share price today?

Unichem Laboratories share price today stands at ₹367.05 as on at the close of the market. Unichem Laboratories share today touched a day high of ₹369.9 and a low of ₹362.25.

What is the 52 week high and 52 week low range for Unichem Laboratories share?

Unichem Laboratories touched a 52 week high of ₹722.35 and a 52 week low of ₹361.05. Unichem Laboratories share price today i.e. is closed at ₹367.05, which is -49.19% down from its 52 week high and 1.66% up from its 52 week low.

What is Unichem Laboratories's market capitalisation today?

Unichem Laboratories market capitalisation is ₹2,584.24 Cr as on .

How to buy Unichem Laboratories shares?

To buy Unichem Laboratories shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for UNICHEMLAB or Unichem Laboratories Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Unichem Laboratories shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Unichem Laboratories trading volume today?

Unichem Laboratories trading volume is 13.10K as on . This means that 13.10K shares of Unichem Laboratories were bought and sold on the stock market during today's trading session.